Showing results (411-420 of 463) with videos related to
Sort By:
Pageof 47
Hemasphere|November 1, 2023
Momelotinib in Myelofibrosis Patients With Thrombocytopenia: Post Hoc Analysis From Three Randomized Phase 3 TrialsJean-Jacques Kiladjian, Alessandro M Vannucchi, Aaron T Gerds, et al.Blood Advances|August 8, 2023
Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosisStephen T Oh, Ruben A Mesa, Claire N Harrison, et al.Clinical Transplantation|October 28, 2023
The utilization of molecular microscope in management of heart transplant recipients in the era of noninvasive monitoringYonatan Mehlman, Andrea Fernendez Valledor, Cathrine Moeller, et al.Science Translational Medicine|September 23, 2016
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemiaRizwan Romee, Maximillian Rosario, Melissa M Berrien-Elliott, et al.Circulation. Heart Failure|December 10, 2024
Elevated Donor-Derived Cell-Free DNA Levels Are Associated With Reduced Myocardial Blood Flow but Not Angiographic Cardiac Allograft Vasculopathy: The EVIDENT StudyCathrine M Moeller, Daniel Oren, Andrea Fernandez Valledor, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2024
Plasma Proteomic Signature Predicts Myeloid Neoplasm RiskDuc Tran, J Scott Beeler, Jie Liu, et al.Cancer Medicine|October 24, 2017
Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimenAlaa M Ali, Daniel Weisel, Feng Gao, et al.Cell|October 23, 2018
High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer TherapyMatthew M Gubin, Ekaterina Esaulova, Jeffrey P Ward, et al.ASAIO Journal (American Society for Artificial Internal Organs : 1992)|February 19, 2024
Hemodynamic Optimization by Invasive Ramp Test in Patients Supported With HeartMate 3 Left Ventricular Assist DeviceGal Rubinstein, Cathrine M Moeller, Dor Lotan, et al.British Journal of Cancer|March 2, 2013
Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)Y-K Kang, H-M Chang, J H Yook, et al.Pageof 47